77 related articles for article (PubMed ID: 3126026)
1. Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Letvin NL; Waldmann TA; Kirkman RL
Curr Surg; 1988; 45(1):28-30. PubMed ID: 3126026
[No Abstract] [Full Text] [Related]
2. Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
Shapiro ME; Kirkman RL; Reed MH; Puskas JD; Mazoujian G; Letvin NL; Carpenter CB; Milford EL; Waldmann TA; Strom TB
Transplant Proc; 1987 Feb; 19(1 Pt 1):594-8. PubMed ID: 3103282
[No Abstract] [Full Text] [Related]
3. Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
Reed MH; Shapiro ME; Strom TB; Carpenter CB; Letvin NL; Reimann K; Weinberg DS; Waldmann TA; Kirkman RL
Transplant Proc; 1989 Feb; 21(1 Pt 1):1028-30. PubMed ID: 2650064
[No Abstract] [Full Text] [Related]
4. Phenotypic and functional analysis of kidney infiltrating T cells escaping monoclonal antibody treatment in primate renal transplantation.
Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
Transplant Proc; 1988 Apr; 20(2):205-6. PubMed ID: 3129830
[No Abstract] [Full Text] [Related]
5. The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
Shapiro ME; Reed MH; Strom TB; Carpenter CB; Milford EL; Kirkman RL
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):58-60. PubMed ID: 2816938
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model.
Hayes JM; Spencer W; Valenzuela R; Caulfield M; Novick AC
Transplant Proc; 1989 Feb; 21(1 Pt 1):1006-9. PubMed ID: 2650061
[No Abstract] [Full Text] [Related]
7. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Weinberg DS; Reimann KA; Letvin NL; Waldmann TA; Kirkman RL
Transplantation; 1989 Jan; 47(1):55-9. PubMed ID: 2643232
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
Taniguchi N; Miyawaki T; Yachie A
Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
[No Abstract] [Full Text] [Related]
9. Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses.
Cosimi AB; Burton RC; Kung PC; Colvin R; Goldstein G; Lifter J; Rhodes W; Russell PS
Transplant Proc; 1981 Mar; 13(1 Pt 1):499-503. PubMed ID: 7022882
[No Abstract] [Full Text] [Related]
10. Nonhuman primate response to murine and humanized monoclonal antibodies.
Delmonico FL; Cosimi AB
Transplant Proc; 1993 Apr; 25(2 Suppl 1):65-7. PubMed ID: 8096663
[No Abstract] [Full Text] [Related]
11. Early experience with anti-Tac in clinical renal transplantation.
Kirkman RL; Shapiro ME; Carpenter CB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
Transplant Proc; 1989 Feb; 21(1 Pt 2):1766-8. PubMed ID: 2652578
[No Abstract] [Full Text] [Related]
12. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
Kupiec-Weglinski JW; Hahn HJ; Kirkman RL; Volk HD; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris PJ; Strom TB
Transplant Proc; 1988 Apr; 20(2 Suppl 2):207-16. PubMed ID: 3129841
[No Abstract] [Full Text] [Related]
13. Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptor.
Peyronnet P; Le Mauff B; Hourmant M; Cantarovich D; Dubigeon P; Olive P; Mawas C; Delaage M; Hirn J; Jacques Y
Transplant Proc; 1988 Apr; 20(2):300-2. PubMed ID: 3129836
[No Abstract] [Full Text] [Related]
14. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
[No Abstract] [Full Text] [Related]
15. Functional blocking of the interleukin-2 receptor (IL-2R) may be important in the efficacy of IL-2R antibody therapy.
Tellides G; Dallman MJ; Kupiec-Weglinski JW; Diamantstein T; Morris PJ
Transplant Proc; 1987 Oct; 19(5):4231-3. PubMed ID: 3118538
[No Abstract] [Full Text] [Related]
16. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
Tinubu SA; Hakimi J; Kondas JA; Bailon P; Familletti PC; Spence C; Crittenden MD; Parenteau GL; Dirbas FM; Tsudo M
J Immunol; 1994 Nov; 153(9):4330-8. PubMed ID: 7930631
[TBL] [Abstract][Full Text] [Related]
17. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
Maki T; Carville A; Stillman IE; Sato K; Kodaka T; Minamimura K; Ogawa N; Kanamoto A; Gottschalk R; Monaco AP; Marr-Belvin A; Westmoreland SV; Sehgal P
Transplantation; 2008 Mar; 85(6):893-902. PubMed ID: 18360273
[TBL] [Abstract][Full Text] [Related]
18. Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.
Wesley JN; McGee EC; Garmestani K; Brechbiel MW; Yordanov AT; Wu C; Gansow OA; Eckelman WC; Bacher JD; Flynn M; Goldman CK; MacLin M; Schwartz UP; Jackson-White T; Phillip CM; Decker J; Waldmann TA
Nucl Med Biol; 2004 Apr; 31(3):357-64. PubMed ID: 15028248
[TBL] [Abstract][Full Text] [Related]
19. Use of a monoclonal antibody directed against interleukin 2 receptor in recipients of kidney allografts.
Soulillou JP; Le Mauff B; Cantarovich D; Hourmant M; Vie H; Jacques Y
Transplant Proc; 1988 Oct; 20(5 Suppl 6):84-6. PubMed ID: 3051598
[No Abstract] [Full Text] [Related]
20. Technique for primate heterotopic cardiac xenotransplantation.
Michler RE; McManus RP; Smith CR; Sadeghi AN; Rose EA
J Med Primatol; 1985; 14(6):357-62. PubMed ID: 3908687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
